Dao, Vu Thao-Vi <br/><br/>
Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validation.  [electronic resource] 

 -  Free radical biology & medicine  02 2020 
 - 60-69 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-4596 
<br/><br/><label>Standard No.: </label>10.1016/j.freeradbiomed.2019.12.038  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antioxidants--pharmacology<br/>Humans<br/>NADPH Oxidase 1<br/>NADPH Oxidase 4<br/>NADPH Oxidases--genetics<br/>Oxidation-Reduction<br/>Protein Isoforms--genetics<br/>Reactive Oxygen Species